Cynata Therapeutics Limited

DB:51S Stock Report

Market Cap: €30.2m

Cynata Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

DB:51S Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
22 Nov 23Buy€7,479Kilian KellyIndividual94,143€0.079

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 51S?
Owner TypeNumber of SharesOwnership Percentage
Private Companies00%
Public Companies8,088,4034.48%
Individual Insiders12,035,1116.66%
VC/PE Firms23,588,04013.1%
Institutions33,094,66518.3%
General Public103,870,05257.5%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 18 shareholders own 42.51% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
13.1%
Bioscience Managers Pty Ltd
23,588,040€3.9m0%65.02%
13.1%
Phillip Asset Management Ltd.
23,588,040€3.9m0%100.0%
5.26%
Fidelity International Ltd
9,506,625€1.6m0%no data
4.48%
FUJIFILM Holdings Corporation
8,088,403€1.4m0%no data
1.11%
Ross MacDonald
2,000,000€334.6k0%no data
0.96%
Craig Darby
1,729,477€289.3k55.8%no data
0.86%
Malcolm Washer
1,559,534€260.9k0%no data
0.74%
Patrick Walsh
1,341,790€224.5k0%no data
0.66%
Makysm Vodyanyk
1,191,658€199.3k0%no data
0.43%
Miroslawa Rej
771,518€129.1k0%no data
0.43%
Pawel Rej
771,518€129.1k0%no data
0.36%
Jon Bjarnason
655,517€109.7k9.25%no data
0.36%
Rina Bjarnason
655,517€109.7k9.25%no data
0.34%
Kilian Kelly
619,651€103.7k0%no data
0.17%
Paul Wotton
315,309€52.7k0%no data
0.14%
Geoffrey Edward Brooke
257,343€43.0k0%no data
0.064%
Janine Rolfe
116,279€19.5k0%no data
0.028%
Darryl Maher
50,000€8.4k0%no data